BioMarin Pharmaceutical Inc.

06/13/2022 | Press release | Distributed by Public on 06/13/2022 10:41

BioMarin Announces Favorable Results from Global Phase 2 Study of VOXZOGO™ (vosoritide) for Injection in Infants and Young Children with Achondroplasia at The Endocrine Society[...]